113 related articles for article (PubMed ID: 35838586)
1. Immunoglobulin G Subclass Response After Chikungunya Virus Infection.
Patil HP; Gosavi M; Kulkarni R; Mishra AC; Arankalle VA
Viral Immunol; 2022 Jul; 35(6):437-442. PubMed ID: 35838586
[TBL] [Abstract][Full Text] [Related]
2. Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection.
Patil HP; Gosavi M; Mishra AC; Arankalle VA
Am J Trop Med Hyg; 2021 Feb; 104(4):1438-1443. PubMed ID: 33617471
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
[TBL] [Abstract][Full Text] [Related]
4. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
[TBL] [Abstract][Full Text] [Related]
5. Comparative Detection of Immunoglobulin Isotypes and Subclasses against
Borges HDS; Oliveira-Scussel ACM; Oliveira ÂMM; Abdallah VOS; Pajuaba ACAM; Mineo JR
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805611
[TBL] [Abstract][Full Text] [Related]
6. Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India.
Patil HP; Rane PS; Gosavi M; Mishra AC; Arankalle VA
Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1925-1932. PubMed ID: 32504313
[TBL] [Abstract][Full Text] [Related]
7. Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results.
Kizu J; Graham M; Liu W
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543750
[TBL] [Abstract][Full Text] [Related]
8. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
Prince HE; Altrich ML; Nowicki MJ
Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
11. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
12. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis.
Verma P; Bhatnagar S; Kumar P; Chattree V; Parida MM; Hoti SL; Ali S; Rao DN
Clin Chem Lab Med; 2014 Feb; 52(2):297-307. PubMed ID: 24088615
[TBL] [Abstract][Full Text] [Related]
14. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
Prince HE; Seaton BL; Matud JL; Batterman HJ
Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
[TBL] [Abstract][Full Text] [Related]
16. Detection of Chikungunya Virus in Nepal.
Pandey BD; Neupane B; Pandey K; Tun MM; Morita K
Am J Trop Med Hyg; 2015 Oct; 93(4):697-700. PubMed ID: 26195462
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
[TBL] [Abstract][Full Text] [Related]
19. [The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies].
Yan Y; Cui Z; Zhao MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):501-4. PubMed ID: 15489931
[TBL] [Abstract][Full Text] [Related]
20. Evidence of Chikungunya virus circulation in the Terai region of Nepal in 2014 and 2015.
Pandey K; Pandey BD; Chaurasiya RR; Thakur M; Neupane B; Shah Y; Ngwe Tun MM; Morita K
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):294-299. PubMed ID: 29165625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
